Cases 1 - 9 of 9
MSP Recovery Claims, Series LLC v. Amgen Inc. et al
as 2:2023cv03130
Plaintiff:
MSP Recovery Claims, Series LLC
Defendant:
Amgen Inc., Onyx Pharmaceuticals, Inc., Onyx Therapeutics, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Racketeering (RICO) Act
Chronic Disease Fund, Inc. d/b/a Good Days v. Castellanos et al
as 1:2021cv02629
Defendant:
Roberto Castellanos and Health Experiences, Inc.
Plaintiff:
Chronic Disease Fund, Inc. d/b/a Good Days
Cause Of Action: 28 U.S.C. § 1338
CHRONIC DISEASE FUND, INC. v. UNITED STATES OF AMERICA
as 1:2017mc00687
Petitioner:
CHRONIC DISEASE FUND, INC.
Respondent:
UNITED STATES OF AMERICA
Cause Of Action: Motion to Quash Subpoenas
CHRONIC DISEASE FUND, INC. v. UNITED STATES OF AMERICA
as 2:2017cv00322
Petitioner:
CHRONIC DISEASE FUND, INC.
Respondent:
UNITED STATES OF AMERICA
Cause Of Action: 26 U.S.C. § 7609
CHRONIC DISEASE FUND, INC. v. UNITED STATES OF AMERICA
as 2:2017cv00304
Petitioner:
CHRONIC DISEASE FUND, INC.
Respondent:
UNITED STATES OF AMERICA
Cause Of Action: 26 U.S.C. § 7609
CHRONIC DISEASE FUND, INC. v. UNITES STATES OF AMERICA
as 2:2017cv01082
Petitioner:
CHRONIC DISEASE FUND, INC.
Respondent:
UNITED STATES OF AMERICA
Cause Of Action: 26 U.S.C. § 7609
CHRONIC DISEASE FUND, INC. v. UNITED STATES OF AMERICA
as 2:2017cv00942
Petitioner:
CHRONIC DISEASE FUND, INC.
Respondent:
UNITED STATES OF AMERICA
Cause Of Action: 26 U.S.C. § 7609
Chronic Disease Fund, Inc. v. United States of America
as 3:2017cv00721
Petitioner:
Chronic Disease Fund, Inc.
Respondent:
United States of America
Cause Of Action: 26 U.S.C. § 7609 IRS: Petition to Quash IRS Summons
Loretta Carrasco v. Chronic Disease Fund Inc et al
as 5:2014cv00529
Plaintiff:
Loretta Carrasco
Defendant:
Chronic Disease Fund Inc and Does
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
